A major advance in cancer investigation is emerging with the use of mini-antibodies to re-engage damaged p53. This essential malignant suppressor protein is frequently inactivated in many forms of malignancies, leading https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research